Psychological And Social Impact Of Living With Thalassemias
Published on: May 22, 2025
Psychological and social impact of living with thalassemias featured image
Article author photo

Laura Khosravi

BSc Pharmacology and Innovative Therapeutics with honours, Queen Mary University of London

Article reviewer photo

Malavika Jalaja Prasad

MSc. Nanomedicine, Swansea University

Introduction

Diminished or nonexistent haemoglobin production is a characteristic of a class of hereditary blood illnesses known as thalassaemias, which can result in anaemia and other health issues. The impact of these conditions varies; some people have modest symptoms, while others need lifelong blood transfusions and extensive medical treatment.1 

The psychological and social aspects of having thalassaemia are just as important and frequently disregarded as medical therapy, which concentrates on treating physical symptoms including exhaustion, stunted growth, and organ damage. A patient's quality of life can be greatly impacted by the ongoing need for treatment, financial difficulties, and social stigma.2 

This article examines the social and emotional difficulties that people with thalassaemia encounter, including the significant impacts on relationships, work, education, and mental health. It also outlines methods for better coping tactics, support networks, and legislative changes that can enable patients to live happy, meaningful lives despite the challenges posed by their illness.

Understanding Thalassemias

Based on which globin chains  (the protein components of haemoglobin that carry oxygen) are impacted, thalassaemias are often divided into two primary types: alpha-thalassemia and beta-thalassemia.1 Beta-thalassemia results from mutations that impact beta-globin production, whereas alpha-thalassemia is caused by a malfunction in the genes governing alpha-globin formation. From moderate variants like thalassaemia minor, which may show few or no symptoms, to severe cases like beta-thalassemia major, the disease's severity varies greatly.1 Lifelong care is frequently necessary for severe cases, which may need chelation therapy to treat iron excess from multiple transfusions and routine blood transfusions to prevent anaemia.1 Patients with thalassaemia bear a heavy burden due to its chronic nature, which has a variety of effects on their quality of life. In addition to the physical health issues—fatigue, delayed growth, and heightened vulnerability to infections—the illness also has an impact on mental health, resulting in anxiety, sadness, and social isolation. The necessity for holistic care techniques is further highlighted by the financial and societal burdens associated with managing a chronic illness.2

Psychological Impact

Emotional Burden and Anxiety

Anxiety over their health and future is common among thalassaemia patients, especially in children and teenagers. Particularly for young patients, routine medical treatments, including hospital stays, chelation therapy, and transfusions, can be frightening and distressing.2 Feelings of loneliness might result from the physical demands of therapy, which can also interfere with social interactions, peer relationships, and school attendance. Uncertainties regarding the course of the illness, its side effects, and life expectancy also raise anxiety levels.

Depression and Low Self-esteem

Studies indicate that depression is more common in people with long-term conditions, such as thalassaemia.3 Feelings of inadequacy and low self-esteem might result from the ongoing need for medical attention, as well as obvious physical indicators like delayed puberty or limited growth. Adolescence, a time already characterised by heightened sensitivity to social approval and self-image, is when these difficulties are most noticeable. Furthermore, feelings of loneliness and sadness may be exacerbated by the social stigma associated with outward manifestations of disease, such as pallor or dependence on medical equipment.3

Impact on Cognitive Development

According to certain research, children with thalassaemia may experience cognitive development and academic performance issues as a result of chronic anaemia and therapeutic side effects such as iron overload.4 The brain receives less oxygen due to the chronic anaemia linked to thalassaemia, which can affect memory, focus, and general cognitive function .4 Furthermore, even while blood transfusions are essential for treating anaemia, they might cause iron overload, which makes cognitive difficulties much worse.4 Iron accumulation in the brain and other organs can cause neurological impairments that impact memory and learning, and make social and academic situations more challenging.

Post-Traumatic Stress

Some patients may develop post-traumatic stress disorder (PTSD) as a result of repeated exposure to medical procedures and hospital settings.5 Frequent needlestick injuries, transfusions, and procedures might cause children and adolescents to grow up to fear medical environments.

Social Impact

Discrimination and Stigma

Chronic illnesses are linked to discrimination and stigma in many cultures. Because of their disease, people with thalassaemia may be excluded from social events or seen as less capable. Their capacity to develop meaningful relationships, further their education, or find steady jobs may be hampered by this cultural bias.6,7 For people with thalassaemia, the idea of marriage and starting a family is sometimes complicated by worries about genetic transmission, problems with fertility, and social stigma. Many patients feel pressured to stay single or fear rejection from possible companions, which negatively affects their social fulfilment and emotional health. These difficulties are frequently made worse by misconceptions about the illness, such as preconceptions about physical limitations or worries about transmission.6,7 Patients' mental health may be further impacted as a result of feeling alone and having less self-worth.

Impact on Education and Employment

Children with thalassaemia frequently experience academic difficulties and missed school days due to their frequent medical needs. These disturbances can result in fewer employment options as adults, particularly in occupations that require regular attendance or physical labour.7 Furthermore, companies may be reluctant to hire people with chronic illnesses because of false beliefs about their dependability or productivity.

Financial Strain on Families

Families may experience severe financial hardship due to the expense of treating thalassaemia, which includes frequent blood transfusions, iron chelation treatment, and monitoring for complications.8 In countries with low or middle incomes, where healthcare systems may not completely subsidise treatment, families frequently have to choose between paying for medical care and other essentials.8 In addition to further isolating patients from social possibilities, this financial hardship can strain familial ties.

Coping Mechanisms and Support Strategies

Psychological Support

To address the emotional difficulties that people with thalassaemia encounter, counselling and therapy can be quite helpful. In patients with chronic conditions, mindfulness-based therapies and cognitive-behavioural therapy (CBT) have demonstrated promise in lowering anxiety and sadness.9

Peer Support Groups

By joining support groups, patients can interact with people who have gone through similar experiences, which promotes understanding and a sense of community. These groups give people a secure setting in which to communicate their emotions, discuss difficulties, and acknowledge accomplishments.10 Peer support can reduce feelings of loneliness, increase self-esteem, and provide helpful guidance for better condition management.10 Furthermore, these networks frequently make it easier for patients to obtain resources, promote treatment plan adherence, and provide them with the tools they need to deal with obstacles more resiliently. Support groups can also offer families and carers insightful information and emotional solace, enhancing the group's coping mechanisms.

Education and Advocacy

Educational programmes that challenge stereotypes and promote understanding about thalassaemia can help lessen stigma and discrimination. These programmes can help communities adopt a more inclusive and empathetic perspective of people with thalassaemia.11 Furthermore, patients who are better informed about their situation are better equipped to speak up for themselves, find the right kind of help, and deal with personal, social, and medical difficulties. Education improves the quality of life for people with thalassaemia by empowering patients, family, carers, and society at large to foster a more tolerant and understanding environment.

Holistic Care Models

Patients with thalassaemia might benefit greatly from conventional medical care that incorporates psychological and social support to meet their emotional and physical requirements. Multidisciplinary teams, comprising social workers, genetic counsellors, mental health specialists, and others, can offer all-encompassing care that addresses the intricate difficulties of managing a chronic condition.9, 10, 12 To assist patients and their families in managing social isolation, depression, and anxiety, these teams can provide psychosocial interventions, coping mechanisms, and counselling. They can also help patients with family planning, genetic counselling, and navigating the healthcare system, which will ultimately improve their general well-being and quality of life.9,10,12

Policy and Financial Support

The financial burden of managing thalassaemia, which frequently entails expensive, lifelong therapies like frequent blood transfusions, iron chelation therapy, and sophisticated monitoring for problems, can be substantially reduced by governments and non-governmental organisations (NGOs).8 In order to reduce financial hardship, policies that offer insurance coverage, subsidised healthcare, and access to reasonably priced pharmaceuticals are crucial.13 By identifying carriers and facilitating educated reproductive choices, support for genetic screening initiatives, such as premarital and prenatal testing, can help lower the incidence of thalassaemia.13,14

In order to centralise care, provide uniform treatment guidelines, and encourage research into better treatments, governments can also set up national thalassaemia programs. NGOs can support these initiatives by increasing public awareness, providing financial support for medical research, and providing patients with direct aid, including treatment-related travel grants or educational scholarships.13 By contributing knowledge, capital, and infrastructural assistance, international partnerships can further strengthen these efforts, especially in environments with limited resources. When combined, these initiatives can produce a thorough framework that not only attends to patients' urgent medical requirements but also encourages long-term treatment and prevention techniques, thereby enhancing the general quality of life for those who have thalassaemia.

Summary

Beyond the medical treatment of the condition, living with thalassaemia involves a complex interaction of social and psychological issues. A comprehensive strategy that includes community advocacy, policy reforms, and mental health support is needed to address these issues. People with thalassaemia can live happy, empowered lives if society creates a supportive atmosphere and increases awareness.

References

  1. Weatherall DJ, Clegg JB. The Thalassaemia Syndromes [Internet]. 1st ed. Wiley; 2001 [cited 2025 May 16]. Available from: https://onlinelibrary.wiley.com/doi/book/10.1002/9780470696705.
  2. Tarım HŞ, Öz F. Thalassemia Major and Associated Psychosocial Problems: A Narrative Review. Iran J Public Health. 2022; 51(1):12–8.
  3. Shaligram D, Girimaji SC, Chaturvedi SK. Psychological problems and quality of life in children with thalassemia. Indian J Pediatr. 2007; 74(8):727–30.
  4. Bu M, Deng X, Zhang Y, Chen SW, Jiang M, Chen BT. Brain iron content and cognitive function in patients with β-thalassemia. Ther Adv Hematol. 2023; 14:20406207231167050.
  5. Marsac ML, Kassam-Adams N, Delahanty DL, Widaman KF, Barakat LP. Posttraumatic stress following acute medical trauma in children: a proposed model of bio-psycho-social processes during the peri-trauma period. Clin Child Fam Psychol Rev. 2014 Dec;17(4):399-411. doi: 10.1007/s10567-014-0174-2. PMID: 25217001; PMCID: PMC4319666. [Internet]. [date unknown]. Available from: https://europepmc.org/article/pmc/4319666.
  6. Kumar N, Turbitt E, Biesecker BB, Miller IM, Cham B, Smith KC, et al. Managing the need to tell: Triggers and strategic disclosure of thalassemia major in Singapore. Am J Med Genet A. 2019; 179(5):762–9.
  7. Mardhiyah A, Panduragan SL, Mediani HS, Yosep I. Factors Associated With Quality of Life Among Adolescent With Beta Thalassemia in Indonesia: A Cross-Sectional Study. SAGE Open Nurs. 2024; 10:23779608241255638.
  8. Zhen X, Ming J, Zhang R, Zhang S, Xie J, Liu B, et al. Economic burden of adult patients with β-thalassaemia major in mainland China. Orphanet J Rare Dis. 2023; 18(1):252.
  9. Mohamadian F, Bagheri M, Hashemi MS, Komeili Sani H. The Effects of Cognitive Behavioral Therapy on Depression and Anxiety among Patients with Thalassemia: a Randomized Controlled Trial. J Caring Sci. 2018; 7(4):219–24.
  10. Safaei S, Abedi H, Parand S, Karimi M. Evaluation of the Effect of Support-Training System of Peer Group on Promotion of Self-Care in β-Thalassemia Major Patients in Southern Iran. Hemoglobin. 2019; 43(3):198–203.
  11. Hossain MS, Hasan MdM, Raheem E, Islam MS, Al Mosabbir A, Petrou M, et al. Lack of knowledge and misperceptions about thalassaemia among college students in Bangladesh: a cross-sectional baseline study. Orphanet J Rare Dis [Internet]. 2020 [cited 2025 May 16]; 15(1):54. Available from: https://ojrd.biomedcentral.com/articles/10.1186/s13023-020-1323-y.
  12. Anie KA, Massaglia P. Psychological therapies for thalassaemia. Cochrane Database of Systematic Reviews [Internet]. 2014 [cited 2025 May 16]; 2015(4). Available from: http://doi.wiley.com/10.1002/14651858.CD002890.pub2.
  13. Barua T, Sultana K, Barua D, Karnain R, Chowdhury SB, Chowdhury Arzu MA. Expenditure to Treat Thalassemia- A Major Financial Burden. EJMED [Internet]. 2022 [cited 2025 May 16]; 4(5):52–6. Available from: https://www.ej-med.org/index.php/ejmed/article/view/1454.
  14. Farmakis D, Porter J, Taher A, Domenica Cappellini M, Angastiniotis M, Eleftheriou A. 2021 Thalassaemia International Federation Guidelines for the Management of Transfusion-dependent Thalassemia. Hemasphere. 2022; 6(8):e732.
Share

Laura Khosravi

BSc Pharmacology and Innovative Therapeutics with honours, Queen Mary University of London

arrow-right